Human Biology, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center+, Maastricht, The Netherlands.
TiFN, Wageningen, The Netherlands.
Gut. 2022 Jun;71(6):1214-1226. doi: 10.1136/gutjnl-2020-323715. Epub 2022 Feb 8.
Accumulating evidence indicates that the gut microbiome is an important regulator of body weight, glucose and lipid metabolism, and inflammatory processes, and may thereby play a key role in the aetiology of obesity, insulin resistance and type 2 diabetes. Interindividual responsiveness to specific dietary interventions may be partially determined by differences in baseline gut microbiota composition and functionality between individuals with distinct metabolic phenotypes. However, the relationship between an individual's diet, gut microbiome and host metabolic phenotype is multidirectional and complex, yielding a challenge for practical implementation of targeted dietary guidelines. In this review, we discuss the latest research describing interactions between dietary composition, the gut microbiome and host metabolism. Furthermore, we describe how this knowledge can be integrated to develop precision-based nutritional strategies to improve bodyweight control and metabolic health in humans. Specifically, we will address that (1) insight in the role of the baseline gut microbial and metabolic phenotype in dietary intervention response may provide leads for precision-based nutritional strategies; that (2) the balance between carbohydrate and protein fermentation by the gut microbiota, as well as the site of fermentation in the colon, seems important determinants of host metabolism; and that (3) 'big data', including multiple omics and advanced modelling, are of undeniable importance in predicting (non-)response to dietary interventions. Clearly, detailed metabolic and microbial phenotyping in humans is necessary to better understand the link between diet, the gut microbiome and host metabolism, which is required to develop targeted dietary strategies and guidelines for different subgroups of the population.
越来越多的证据表明,肠道微生物组是体重、葡萄糖和脂质代谢以及炎症过程的重要调节剂,它可能在肥胖、胰岛素抵抗和 2 型糖尿病的发病机制中发挥关键作用。个体对特定饮食干预的反应能力可能部分取决于具有不同代谢表型的个体之间基线肠道微生物组组成和功能的差异。然而,个体的饮食、肠道微生物组和宿主代谢表型之间的关系是多向且复杂的,这给实施有针对性的饮食指南带来了挑战。在这篇综述中,我们讨论了描述饮食成分、肠道微生物组和宿主代谢之间相互作用的最新研究。此外,我们还描述了如何整合这些知识来开发基于精准的营养策略,以改善人体的体重控制和代谢健康。具体来说,我们将讨论以下三个方面:(1)了解基线肠道微生物和代谢表型在饮食干预反应中的作用,可能为基于精准的营养策略提供线索;(2)肠道微生物群对碳水化合物和蛋白质的发酵平衡,以及发酵的部位在结肠中,似乎是宿主代谢的重要决定因素;(3)“大数据”,包括多种组学和先进的建模,在预测饮食干预的反应方面具有不可否认的重要性。显然,需要对人类进行详细的代谢和微生物表型分析,以更好地理解饮食、肠道微生物组和宿主代谢之间的联系,这是为不同人群开发有针对性的饮食策略和指南所必需的。